ArticleMolecular therapy : the journal of the American Society of Gene Therapy2013

Reducing mitochondrial ROS improves disease-related pathology in a mouse model of ataxia-telangiectasia.

Anthony D D'Souza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.